Particle.news
Download on the App Store

Diekmeier Daughter to Begin Weeklong Nuclear-Medicine Therapy in Würzburg on Monday

Cautious hope follows a November scan that showed the radioactive agent binding to her tumors.

Overview

  • The Imaza therapy involves injecting a radioactive compound that targets cancer cells, requiring Delani to remain isolated as her parents watch through a glass partition.
  • Delani, 14, was diagnosed with an adrenal gland tumor in January and later developed lung metastases, leading to three lung surgeries and multiple unsuccessful chemotherapies and immunotherapy.
  • Doctors previously put her survival chances at about five percent, and she was at one point classified as a palliative patient before the family found new specialists pursuing this option.
  • Dennis and Dana Diekmeier described the emotional strain in interviews with RTL and Sky’s Meine Geschichte, balancing fear with renewed optimism as treatment begins.
  • The family plans a quiet Christmas and a possible recuperation trip to Austria if her condition allows, with the therapy’s effectiveness to be evaluated after the weeklong course.